{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:25:04Z","timestamp":1773181504914,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["PROJ-CAPESPRINT1047264P"],"award-info":[{"award-number":["PROJ-CAPESPRINT1047264P"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s42770-024-01325-x","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T07:02:21Z","timestamp":1715583741000},"page":"1811-1816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel aza-bicyclic 2-isoxazoline acylhydrazone hybrids and their synergistic potential with fluconazole against a drug-resistant Candida albicans strain"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2495-4821","authenticated-orcid":false,"given":"Ianca Karine Prudencio","family":"de Albuquerque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4930-1093","authenticated-orcid":false,"given":"D\u00e9bora Lopes","family":"de Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5557-8876","authenticated-orcid":false,"given":"Franz","family":"de Assis Graciano dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe Neves","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9699-530X","authenticated-orcid":false,"given":"Valderes Moraes","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1803-138X","authenticated-orcid":false,"given":"Ant\u00f4nio Rodolfo","family":"de Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5305-5545","authenticated-orcid":false,"given":"Danielle Patr\u00edcia Cerqueira","family":"Mac\u00eado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4184-7366","authenticated-orcid":false,"given":"Rejane Pereira","family":"Neves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"1325_CR1","doi-asserted-by":"publisher","first-page":"100137","DOI":"10.1016\/j.crmicr.2022.100137","volume":"3","author":"GKK Reddy","year":"2022","unstructured":"Reddy GKK, Padmavathi AR, Nancharaiah YV (2022) Fungal infections: Pathogenesis, antifungals and alternate treatment approaches. Curr Res Microb Sci 3:100137. https:\/\/doi.org\/10.1016\/j.crmicr.2022.100137","journal-title":"Curr Res Microb Sci"},{"key":"1325_CR2","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","volume":"17","author":"DS Perlin","year":"2017","unstructured":"Perlin DS, Rautemaa-Richardson R, Alastruey-Izquierdo A (2017) The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis 17:e383\u2013e392. https:\/\/doi.org\/10.1016\/S1473-3099(17)30316-X","journal-title":"Lancet Infect Dis"},{"key":"1325_CR3","doi-asserted-by":"publisher","unstructured":"Kotey FC, Dayie NT, Tetteh-Uarcoo PB, Donkor ES (2021) Candida Bloodstream Infections: changes in epidemiology and increase in Drug Resistance. Infect Dis (Auckl) 14:117863372110269. https:\/\/doi.org\/10.1177\/11786337211026927","DOI":"10.1177\/11786337211026927"},{"key":"1325_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","volume":"124","author":"MS Shaveta","year":"2016","unstructured":"Shaveta MS, Singh P (2016) Hybrid molecules: the privileged scaffolds for various pharmaceuticals. Eur J Med Chem 124:500\u2013536. https:\/\/doi.org\/10.1016\/j.ejmech.2016.08.039","journal-title":"Eur J Med Chem"},{"key":"1325_CR5","first-page":"101","volume":"66","author":"PC Sharma","year":"2009","unstructured":"Sharma PC, Sharma SV, Jain S, Singh D, Suresh B (2009) Synthesis of some new isoxazoline derivatives as possible anti-Candida agents. Acta Pol Pharm - Drug Res 66:101\u2013104","journal-title":"Acta Pol Pharm - Drug Res"},{"key":"1325_CR6","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1039\/C4NJ00244J","volume":"38","author":"PN Kalaria","year":"2014","unstructured":"Kalaria PN, Satasia SP, Raval DK (2014) Synthesis, identification and in vitro biological evaluation of some novel 5-imidazopyrazole incorporated pyrazoline and isoxazoline derivatives. New J Chem 38:2902\u20132910. https:\/\/doi.org\/10.1039\/C4NJ00244J","journal-title":"New J Chem"},{"key":"1325_CR7","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1007\/s00044-015-1385-x","volume":"24","author":"MD Nikam","year":"2015","unstructured":"Nikam MD, Mahajan PS, Damale MG et al (2015) Synthesis, molecular docking and biological evaluation of some novel tetrazolo[1,5-a]quinoline incorporated pyrazoline and isoxazoline derivatives. Med Chem Res 24:3372\u20133386. https:\/\/doi.org\/10.1007\/s00044-015-1385-x","journal-title":"Med Chem Res"},{"key":"1325_CR8","unstructured":"De Almeida VM (2008) S\u00edntese assim\u00e9trica de 3-carboxamidas enantiomericamente puras e de hidrazidas e arilhidrazonas, derivadas do novo heterociclo 7-(benzoil)-2-isoxazolina[5,4-b]pirrolidina. Avalia\u00e7\u00e3o das atividades biol\u00f3gicas. PhD Thesis, Federal University of Pernambuco"},{"key":"1325_CR9","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1039\/C9MD00276F","volume":"10","author":"FVB Mota","year":"2019","unstructured":"Mota FVB, de Ara\u00fajo Neta MS, de Souza Franco E et al (2019) Evaluation of anti-inflammatory activity and molecular docking study of new aza-bicyclic isoxazoline acylhydrazone derivatives. Medchemcomm 10:1916\u20131925. https:\/\/doi.org\/10.1039\/C9MD00276F","journal-title":"Medchemcomm"},{"key":"1325_CR10","volume-title":"Reference method for broth dilution Antifungal susceptibility testing of yeasts; approved Standard. M27-A4","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute (2012) Reference method for broth dilution Antifungal susceptibility testing of yeasts; approved Standard. M27-A4. CLSI, Wayne"},{"key":"1325_CR11","unstructured":"Moody JA (1992) Synergism testing: broth microdilution checkerboard and broth macrodilution methods. In: H. D. Eisenberg (ed.), Clinical microbiology procedures handbook. Washington, DC: American Society for Microbiology 5.18.1\u20135.18.23"},{"key":"1325_CR12","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1128\/aac.42.4.744","volume":"42","author":"JG Den Hollander","year":"1998","unstructured":"Den Hollander JG, Mouton JW, Verbrugh HA (1998) Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics. Antimicrob Agents Chemother 42:744\u2013748. https:\/\/doi.org\/10.1128\/aac.42.4.744","journal-title":"Antimicrob Agents Chemother"},{"key":"1325_CR13","doi-asserted-by":"publisher","unstructured":"Barchiesi F, Di Francesco LF, Compagnucci P, Arzeni D, Giacometti A, Scalise G (1998) In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. J Antimicrob Chemother 41:59\u201365. https:\/\/doi.org\/10.1093\/jac\/41.1.59","DOI":"10.1093\/jac\/41.1.59"},{"key":"1325_CR14","doi-asserted-by":"publisher","unstructured":"Arai R, Sugita T, Nishikawa A (2005) Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans. Mycoses 48:38\u201341. https:\/\/doi.org\/10.1111\/j.1439-0507.2004.01052.x","DOI":"10.1111\/j.1439-0507.2004.01052.x"},{"key":"1325_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52:1\u20131. https:\/\/doi.org\/10.1093\/jac\/dkg301","journal-title":"J Antimicrob Chemother"},{"key":"1325_CR16","doi-asserted-by":"publisher","first-page":"46731","DOI":"10.1021\/acsomega.2c05788","volume":"7","author":"M Chalkha","year":"2022","unstructured":"Chalkha M, Nour H, Chebbac K et al (2022) Synthesis, characterization, DFT mechanistic study, antimicrobial activity, molecular modeling, and ADMET properties of Novel Pyrazole-Isoxazoline hybrids. ACS Omega 7:46731\u201346744. https:\/\/doi.org\/10.1021\/acsomega.2c05788","journal-title":"ACS Omega"},{"issue":"2","key":"1325_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/1570180814666171003145227","volume":"15","author":"A Erguc","year":"2018","unstructured":"Erguc A et al (2018) Synthesis and biological evaluation of new quinoline-based thiazolyl hydrazone derivatives as potent antifungal and anticancer agents. Lett Drug Des Discov 15(2):193\u2013202. https:\/\/doi.org\/10.2174\/1570180814666171003145227","journal-title":"Lett Drug Des Discov"},{"key":"1325_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s00044-019-02390-w","volume":"28","author":"NR Appna","year":"2019","unstructured":"Appna NR et al (2019) Design and synthesis of novel 4-hydrazone functionalized\/1,2,4-triazole fused pyrido[2,3-d]pyrimidine derivatives, their evaluation for antifungal activity and docking studies. Med Chem Res 28:1509\u20131528. https:\/\/doi.org\/10.1007\/s00044-019-02390-w","journal-title":"Med Chem Res"},{"issue":"1","key":"1325_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.31032\/IJBPAS\/2019\/8.1.4606","volume":"8","author":"HAH Al Ghamdi","year":"2019","unstructured":"Al Ghamdi HAH, Alam MM (2019) Synthesis and characterization of 1,2,3-triazole and hydrazone derivatives as potent antimicrobial agent. Int J Bio Pharma Allied Sci 8(1):37\u201352. https:\/\/doi.org\/10.31032\/IJBPAS\/2019\/8.1.4606","journal-title":"Int J Bio Pharma Allied Sci"},{"key":"1325_CR20","unstructured":"Al Ghamdi HAH, Nazreen S, Alam MM (2020) In vitro antimicrobial potentialities and in silico absorption, distribution, metabolism, and elimination predictions of new hydrazone-1,2,3-triazole hybrids. Indian J Heterocycl Chem 30(1):55\u201363"},{"key":"1325_CR21","doi-asserted-by":"publisher","first-page":"10458","DOI":"10.1039\/C9NJ01532A","volume":"43","author":"B Sankar","year":"2019","unstructured":"Sankar B, Harikrishnan M, Raja R et al (2019) Design of a simple and efficient synthesis for bioactive novel pyrazolyl-isoxazoline hybrids. New J Chem 43:10458\u201310467. https:\/\/doi.org\/10.1039\/C9NJ01532A","journal-title":"New J Chem"},{"issue":"3","key":"1325_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/aac.00701-17","volume":"62","author":"HE Eldesouky","year":"2018","unstructured":"Eldesouky HE, Mayhoub A, Hazbun TR, Seleem MN (2018) Reversal of Azole Resistance in Candida albicans by Sulfa Antibacterial drugs. Antimicrob Agents Chemother 62(3):10\u20131128. https:\/\/doi.org\/10.1128\/aac.00701-17","journal-title":"Antimicrob Agents Chemother"},{"key":"1325_CR23","unstructured":"Albuquerque IKP (2019) Avalia\u00e7\u00e3o da atividade anti-Candida de h\u00edbridos de 2-isoxazolina azabic\u00edclica e sua intera\u00e7\u00e3o com fluconazol. Dissertation, Federal University of Pernambuco"},{"issue":"4","key":"1325_CR24","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0732-8893(02)00473-X","volume":"44","author":"CR Bonapace","year":"2002","unstructured":"Bonapace CR et al (2002) Comparison of methods of interpretation of checkerboard synergy testing. Diagn Microbiol Infect Dis 44(4):363\u2013366","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1325_CR25","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1568026622666220105102508","volume":"22","author":"FVB Mota","year":"2022","unstructured":"Mota FVB, Coutinho FN, de Carvalho VMF et al (2022) Antinociceptive effects of Aza-Bicyclic Isoxazoline-Acylhydrazone derivatives in different models of Nociception in mice. Curr Top Med Chem 22:247\u2013258. https:\/\/doi.org\/10.2174\/1568026622666220105102508","journal-title":"Curr Top Med Chem"},{"key":"1325_CR26","unstructured":"Silva MB (2023) Descri\u00e7\u00e3o cl\u00ednico-epidemiol\u00f3gica da esporotricose humana e avalia\u00e7\u00e3o de h\u00edbridos moleculares de 2-isoxazolina aza-bic\u00edclica com potencial anti-Sporothrix. Dissertation, Federal University of Pernambuco"},{"key":"1325_CR27","unstructured":"Santana DL (2023) Avalia\u00e7\u00e3o da atividade antimicrobiana de h\u00edbridos moleculares de 2-isoxazolina aza-bic\u00edclica frente isolados fenotipicamente resistentes de Aspergillus fumigatus Dissertation, Federal University of Pernambuco"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-024-01325-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-024-01325-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-024-01325-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T02:25:07Z","timestamp":1717640707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-024-01325-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1325"],"URL":"https:\/\/doi.org\/10.1007\/s42770-024-01325-x","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"21 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no financial interests or conflicts to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}